China Industrial Asset Management logo

China Industrial Asset Management

Asia, Shanghai, China, Shanghai

Description

China Industrial Asset Management is an asset management company under China Industrial Bank.

Investor Profile

China Industrial Asset Management has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Medical, Pharmaceutical.

Stage Focus

  • Series C (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does China Industrial Asset Management frequently co-invest with?

GreatWall Fund
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
CITIC Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Advantech Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Forebright Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
China Merchants Health
Asia, Hunan, China, Nanshan
Co-Investments: 1
CD Capital
Asia, Zhejiang, China, Ningbo
Co-Investments: 1
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
E Fund Management Co.,LTD.
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Co-Investments: 1
China Reform Fund Management
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by China Industrial Asset Management?

Tuoxin Tiancheng

Fuzhou, Jiangxi, China

Tuoxin Tiancheng is a clinical-stage biopharmaceutical company focused on the development of immunotherapy for solid tumors.

BiotechnologyMedical
Series BJul 15, 2025
Amount Raised: $40,000,000
Stemirna

Beijing, Beijing, China

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

BiotechnologyMedicalPharmaceutical
Series CJun 3, 2021
Amount Raised: $187,388,738